These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36698453)

  • 1. Neuropathology-Independent Association Between
    Qian J; Zhang Y; Betensky RA; Hyman BT; Serrano-Pozo A
    Neurol Genet; 2023 Feb; 9(1):e200055. PubMed ID: 36698453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of
    Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
    Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOEε2 is associated with milder clinical and pathological Alzheimer disease.
    Serrano-Pozo A; Qian J; Monsell SE; Betensky RA; Hyman BT
    Ann Neurol; 2015 Jun; 77(6):917-29. PubMed ID: 25623662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related Tauopathy.
    Smirnov DS; Salmon DP; Galasko D; Edland SD; Pizzo DP; Goodwill V; Hiniker A
    Ann Neurol; 2022 Sep; 92(3):425-438. PubMed ID: 35696592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies.
    Maldonado-Díaz C; Hiya S; Yokoda RT; Farrell K; Marx GA; Kauffman J; Daoud EV; Gonzales MM; Parker AS; Canbeldek L; Kulumani Mahadevan LS; Crary JF; White CL; Walker JM; Richardson TE
    Acta Neuropathol; 2024 Mar; 147(1):58. PubMed ID: 38520489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design.
    Qian J; Hyman BT; Betensky RA
    JAMA Neurol; 2017 May; 74(5):540-548. PubMed ID: 28288263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities.
    Katsumata Y; Shade LM; Hohman TJ; Schneider JA; Bennett DA; Farfel JM; ; Kukull WA; Fardo DW; Nelson PT
    Neurobiol Dis; 2022 Nov; 174():105880. PubMed ID: 36191742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Components of the choline oxidation pathway modify the association between the apolipoprotein ε4 gene variant and cognitive decline in patients with dementia.
    Hildre AS; Solvang SH; Aarsland D; Midtun Ø; McCann A; Ervik AO; Nygård O; Ueland PM; Nordrehaug JE; Giil LM
    Brain Res; 2020 Jan; 1726():146519. PubMed ID: 31654640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild cognitive impairment.
    Giannisis A; Al-Grety A; Carlsson H; Howell JC; Hu WT; Kultima K; Nielsen HM
    Alzheimers Res Ther; 2023 Jul; 15(1):119. PubMed ID: 37400888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly.
    Warzok RW; Kessler C; Apel G; Schwarz A; Egensperger R; Schreiber D; Herbst EW; Wolf E; Walther R; Walker LC
    Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):33-9. PubMed ID: 9539408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort.
    Nelson RS; Abner EL; Jicha GA; Schmitt FA; Di J; Wilcock DM; Barber JM; Van Eldik LJ; Katsumata Y; Fardo DW; Nelson PT
    Acta Neuropathol Commun; 2023 Jun; 11(1):89. PubMed ID: 37269007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathologic validation of the Alzheimer's Questionnaire.
    Mohebpour I; Malek-Ahmadi M; Virden T; Breitmeyer A; Sabbagh MN; Auman B; Belden CM; Choudhury P; Arch A; Davis K; Cline C; Moorley N; Atri A; Serrano G; Beach TG
    Aging Clin Exp Res; 2022 Nov; 34(11):2905-2909. PubMed ID: 36031683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
    Grober E; Qi Q; Kuo L; Hassenstab J; Perrin RJ; Lipton RB
    J Alzheimers Dis; 2021; 80(1):185-195. PubMed ID: 33492286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE ε4, Alzheimer's disease neuropathology and sleep disturbance, in individuals with and without dementia.
    Blackman J; Love S; Sinclair L; Cain R; Coulthard E
    Alzheimers Res Ther; 2022 Mar; 14(1):47. PubMed ID: 35354468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologies Underlying Longitudinal Cognitive Decline in the Oldest Old.
    Nguyen MT; Mattek N; Woltjer R; Howieson D; Silbert L; Hofer S; Kaye J; Dodge H; Erten-Lyons D
    Alzheimer Dis Assoc Disord; 2018; 32(4):265-269. PubMed ID: 30052535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Alzheimer's Disease, Lewy Body and Vascular Co-Pathologies on Clinical Transition to Dementia in a National Autopsy Cohort.
    Pillai JA; Butler RS; Bonner-Jackson A; Leverenz JB
    Dement Geriatr Cogn Disord; 2016; 42(1-2):106-16. PubMed ID: 27623397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.
    Serrano-Pozo A; Qian J; Muzikansky A; Monsell SE; Montine TJ; Frosch MP; Betensky RA; Hyman BT
    J Neuropathol Exp Neurol; 2016 Jun; 75(6):516-26. PubMed ID: 27105663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.